In the run-up to the MedCity INVEST conference showcasing healthcare innovation, investment and startups, we’re casting a spotlight on some of the healthcare investor judges taking part in the INVEST Pitch Perfect contest. The…
Continue Reading
The digital health world has found itself in a “probably historically bad financing and funding environment,” noted Michael Greeley, partner at Flare Capital Partners, during a panel held last week at the HIMSS conference…
Continue Reading
RNA-focused digital therapeutics company Flamingo Therapeutics added a new member to its board of directors, Dr. Ezra Cohen. Flamingo produces RNA therapies for oncology and is backed by investors such as Andera Partners, Bpifrance Large…
Continue Reading
Guidance released this week from the Cybersecurity and Infrastructure Security Agency, Federal Bureau of Investigation and other U.S. and international partners outlines best practices for defending against “living off the land” cyber activity –…
Continue Reading
The inaugural Accelerating FemTech programme has successfully concluded, led by the Health Innovation Network (HIN) South London in collaboration with all 15 health innovation networks and various partners from across the UK. The initiative,…
Continue Reading
CombinAble.AI, the latest venture from AION Labs, represents a pioneering leap in therapeutic antibody development. By integrating advanced AI technologies with computational methods, CombinAble.AI aims to streamline the discovery process for biotherapeutics. Led by…
Continue Reading
Health systems rely on their third-party partners. Any given hospital in this country likely has contracts with hundreds of companies providing the services they need to maintain daily operations — from telehealth platforms to…
Continue Reading
ORLANDO—During HIMSS24 Views from the Top session, “Digital health startups: Harnessing innovation to disrupt and improve care delivery,” experts relayed that strength in an executive team (not necessarily a product) and solutions that solve…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup company CombineAble.AI, which will speed up the development of therapeutics by addressing challenges…
Continue Reading
Strategic Partnerships New Consortium Aims to Ensure Responsible Use of AI in Healthcare A new initiative, the Trustworthy & Responsible AI Network (TRAIN), was announced at the HIMSS 2024 Global Health Conference. Through collaboration,…
Continue Reading
